rifampin has been researched along with Primary-Myelofibrosis* in 3 studies
3 other study(ies) available for rifampin and Primary-Myelofibrosis
| Article | Year |
|---|---|
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Rifampin; Treatment Outcome; Tuberculosis, Miliary | 2016 |
Brucellosis presenting as myelofibrosis: first case report.
We describe the case of a 29-year-old woman who presented with pancytopenia and myelofibrosis. Brucella melitensis was identified in her blood. The patient recovered completely with doxycycline and rifampin. A repeat bone marrow biopsy showed hypercellularity without myelofibrosis. Bone marrow findings in cases of pancytopenia due to brucellosis reveal normocellularity, hypercellularity, hemophagocytosis, or granuloma. To our knowledge this is the first report of brucellosis causing myelofibrosis. Brucellosis should be considered as a possible cause of myelofibrosis in endemic areas. Topics: Adult; Biopsy; Bone Marrow; Brucella melitensis; Brucellosis; Doxycycline; Female; Humans; Pancytopenia; Primary Myelofibrosis; Rifampin | 2010 |
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis.
Topics: Anti-Bacterial Agents; Bacteriuria; Biofilms; Catheter-Related Infections; Chloramphenicol; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Equipment Contamination; Gram-Negative Bacterial Infections; Humans; Primary Myelofibrosis; Rifampin; Stenotrophomonas maltophilia; Urinary Catheterization; Urinary Retention | 2010 |